Rui L. Luo
No. 16, Ren Min Nan Road
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Ecological Quality Assessment of Chengdu's Main Urban Area Based on Remote Sensing Ecological Index and Its Response Analysis to Functional Zoning
Journal: Huan jing ke xue= Huanjing kexue
Published: July 20, 2026
Nanomaterial-based drug delivery systems: From intelligent delivery to clinical translation and precision nanomedicine.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 16, 2026
Temporal and Spatial Pattern Changes of Vegetation Net Primary Productivity in Sichuan Province and the Analysis of Its Driving Factors
Journal: Huan jing ke xue= Huanjing kexue
Published: May 20, 2026
A Theranostic Study of 177Lu-Labeled Anti-ADAM9 Antibody for the Treatment of Triple-Negative Breast Cancer.
Journal: Bioconjugate chemistry
Published: May 19, 2026
Preclinical Evaluation of 5T4-Targeted [89Zr]Zr-DFO-HB5 Immuno-PET Imaging and Comparison of 161Tb vs 177Lu Radionuclide Therapy for Colorectal Cancer.
Journal: Journal of medicinal chemistry
Published: April 15, 2026
Transparent, bio-based dielectric films with ultrahigh breakdown strength fabricated from hydrogen-bonded cellulose acetate and tannic acid for energy storage.
Journal: Carbohydrate polymers
Published: April 15, 2026
Hypertension and frailty in older adults: a bibliometric analysis and knowledge mapping based on Web of Science, Scopus, and PubMed (1973-2025).
Journal: Frontiers in medicine
Published: March 05, 2026
High transparent, high strength and high energy storage capability of cellulose triacetate films via incorporating cellulose nanocrystal.
Journal: Carbohydrate polymers
Published: February 16, 2026
A hierarchical self-adjuvanted nanoCRISPR-based vaccine restores endogenous immune recognition and surveillance to amplify adaptive immune responses.
Journal: Biomaterials
Published: January 22, 2026
161Tb-PSMA radioligand therapy in prostate cancer: current evidence and future perspectives.
Journal: Frontiers in oncology
Published: November 10, 2025
Tumor-activated dual metabolic nanomodulator turns over tolerogenic tumor control and unleashes systemic immune responses.
Journal: Journal of nanobiotechnology
Published: October 26, 2025
Last Updated: 09/26/2026